Pfizer - Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata 2026 (With Up to USD 100,000 in Funding)

Get latest opportunities sent your Inbox

---

Join our Telegram Channel Follow us on WhatsApp

About Pfizer - Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata

The Pfizer Research Grant Request for Proposals (RFP) is designed to support independent research that generates real-world evidence (RWE) on the effectiveness of early initiation of ritlecitinib in treating alopecia areata.The programme seeks to determine whether starting treatment earlier in the disease course leads to improved clinical outcomes compared with delayed treatment or conventional treatment pathways. The findings are expected to enhance understanding of treatment timing and inform future clinical decision-making.

• Sponsor Organisation: Pfizer

Benefits of Pfizer - Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata

Grant Amount

Applicants may request funding of up to:

• USD 100,000 per project

Pfizer - Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata Requirements

• The funding opportunity is open to organizations located in the United States.
• Eligible organizations include research institutions capable of conducting independent clinical or observational research.
• Individuals are not eligible to receive funding directly.

Principal Investigator Requirements

The Principal Investigator (PI) must:

• Be located in the United States.
• Be employed by or contracted with the requesting organization.
• Hold an eligible professional qualification.

Acceptable qualifications include:

• MD
• PhD
• Equivalent doctoral degree
• Advanced nursing degree
• Pharmacy degree
• Physiotherapy degree
• Social Work degree

Organizational Requirements

The requesting organization must:

• Be legally able to receive grant funding from Pfizer Inc.
• Play a substantive role in the proposed project.
• Clearly define the responsibilities of all participating institutions if multiple organizations are involved.

Independent medical practice groups and individual applicants are not eligible.

Application Date and Process

• Click on the link to the application website to apply.

Application Deadline

14 July, 2026

Opportunity Application

View details of Pfizer - Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata

Apply for Pfizer - Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata